Does Evidence Travel Well? Rethinking Guidelines and Real-World Effectiveness in Middle-Income Health Systems - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

How Well Does Evidence Translate? Reassessing Guidelines and Real-World Effectiveness in Middle-Income Health Systems

  • By

  • Vinícius Brenner Felice

  • Cassiano Teixeira

  • October 7, 2026

Share

  • 1

    Guideline effectiveness depends on health-system capacity, including staffing, infrastructure, and reliable care pathways.

  • 2

    In Brazilian cohorts, mortality among mechanically ventilated patients was 51%, and mortality among invasively ventilated patients with COVID-19 neared 80%.

  • 3

    In the OGAA cohort, 90-day mortality after esophagectomy was 9.4% in low- and middle-income countries and 3.7% in high-income settings, despite similar major-complication rates.

  • 4

    Stroke-unit effectiveness in resource-limited settings depends on consistent supportive care, including dysphagia screening, pneumonia prevention, mobilization, and nutritional support.

  • 5

    Trials in Zambia and Africa found higher short-term mortality with aggressive fluid resuscitation protocols when comparable critical care support was unavailable.

Original Source(s)

Related Content